Translational Combinatorial Therapies for Human Cancers
In the past, treatment for cancer was simply the surgical excision of the tumor and some surrounding tissue. As cancer treatment evolved, other methods were added after the initial surgical procedure, including radiation treatment and chemotherapeutics.
These chemotherapeutic drugs play a key role in promoting tumor shrinkage and attempts to prevent relapse.
Current scientific techniques allow Dr. Copland's Cancer Biology and Translational Oncogenomics Laboratory to identify novel genetic targets for specific subtypes of cancer.
One goal of the lab is to test drugs that manipulate these novel genes and proteins in combinations that are specific to the subtype of cancer.
Dr. Copland and his research team hope to identify synergistic combinations and explore their mechanisms of action in order to promote bench-to-bedside research and to replace the current standard of care with more effective therapies that have fewer side effects.
Review poster presentations related to Dr. Copland's research on translational combinatorial therapies for human cancers (PDF files requiring Adobe Reader):